ConductScience.org, home

Trial · NCT06256432

Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome

NCT06256432, Phase 2, Active not recruiting, Noorik Biopharmaceuticals AG

3 sourcestrials-2026-11-12-0.4.0

Download JSON
Cite this record

ConductScience Library. Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome. Trials, record NCT06256432. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06256432

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome
NCT number
NCT06256432
Status
Active not recruiting
Phases
Phase 2
Enrollment
54 participants, estimated
Lead sponsor
Noorik Biopharmaceuticals AG
Conditions
Hepatorenal Syndrome, Liver Cirrhosis, Acute Kidney Injury, Ascites Hepatic
Interventions
Ambrisentan, Terlipressin
First posted
2024-02-13
Last updated
2026-04-13

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in estimated GFR (eGFR) from baseline4 daysAs determined by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula
SecondaryProportion of patients achieving Hepatorenal Syndrome reversal14 daysReversal defined as two consecutive serum creatinine values \< 1.5 mg/dL (132 µmol/L) within 24 hours
SecondaryProportion of subjects experiencing Hepatorenal Syndrome recurrence60 daysRecurrence defined as the appearance of Hepatorenal Syndrome satisfying all clinical trial entry criteria
SecondaryOverall survival60 daysProportion of participants alive in each treatment arm

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers9

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
594643BACKGROUNDPubMed
1435931BACKGROUNDPubMed
8667963BACKGROUNDPubMed
14724140BACKGROUNDPubMed
17886336BACKGROUNDPubMed
19506099BACKGROUNDPubMed
24107793BACKGROUNDPubMed
25631669BACKGROUNDPubMed
33295121BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Source

Release
trials-2026-11-12-0.4.0
Release manifest SHA-256
0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
Registry capture
2026-11-12
Results copy, AACT
2026-03-23
NIH clinical studies file
2026-11-13

Source ClinicalTrials.gov

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06256432

GET https://conductscience.org/api/trials/v1/NCT06256432/registered